Basic fibroblast growth factor causes urinary bladder overactivity through gap junction generation in the smooth muscle

American Journal of Physiology - Renal Physiology

Volumn 297, Issue 1, 2009, Pages

  Imamura, Masaaki ^a,b   Negoro, Hiromitsu ^a,b   Kanematsu, Akihiro ^a   Yamamoto, Shingo ^c   Kimura, Yu ^b   Nagane, Kentaro ^b   Yamasaki, Toshinari ^a   Kanatani, Isao ^a,b   Ito, Noriyuki ^a   Tabata, Yasuhiko ^b   Ogawa, Osamu ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

bFGF; Bladder smooth muscle cell; Connexin 43; ERK; Hypersensitivity

Indexed keywords

ACETYLCHOLINE; BASIC FIBROBLAST GROWTH FACTOR; CHOLINERGIC RECEPTOR STIMULATING AGENT; CONNEXIN 43; GAP JUNCTION PROTEIN; GELATIN; GLYCYRRHETINIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CAPACITY; BLADDER MUSCLE; BLADDER NECK STENOSIS; BLADDER WALL; CONTROLLED STUDY; DETRUSOR MUSCLE; FEMALE; GAP JUNCTION; HYDROGEL; NONHUMAN; OVERACTIVE BLADDER; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE; URINARY FREQUENCY; UROTHELIUM;

EID: 67650673824     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90207.2008     Document Type: Article

References (43)

1. Abrams P. Describing bladder storage function: overactive bladder syndrome and detrusor overactivity. Urology 62: 28-37, 2003.
2. Abrams P, Andersson KE. Muscarinic receptor antagonists for overactive bladder. BJU Int 100: 987-1006, 2007.
3. Brading AF. A myogenic basis for the overactive bladder. Urology 50: 57-67, 1997.
4. Carystinos GD, Kandouz M, Alaoui-Jamali MA, Batist G. Unexpected induction of the human connexin 43 promoter by the ras signaling pathway is mediated by a novel putative promoter sequence. Mol Pharmacol 63: 821-831, 2003.
5. Christ GJ, Day NS, Day M, Zhao W, Persson K, Pandita RK, Andersson KE. Increased connexin43-mediated intercellular communication in a rat model of bladder overactivity in vivo. Am J Physiol Regul Integr Comp Physiol 284: R1241-R1248, 2003.
6. de Groat WC. A neurologic basis for the overactive bladder. Urology 50: 36-52, 1997.
7. Doble BW, Chen Y, Bosc DG, Litchfield DW, Kardami E. Fibroblast growth factor-2 decreases metabolic coupling and stimulates phosphorylation as well as masking of connexin43 epitopes in cardiac myocytes. Circ Res 79: 647-658, 1996.
8. Doble BW, Kardami E. Basic fibroblast growth factor stimulates connexin-43 expression and intercellular communication of cardiac fibroblasts. Mol Cell Biochem 143: 81-87, 1995.
9. Falk MM. Biosynthesis and structural composition of gap junction intercellular membrane channels. Eur J Cell Biol 79: 564-574, 2000.
10. Fry CH, Sui GP, Severs NJ, Wu C. Spontaneous activity and electrical coupling in human detrusor smooth muscle: implications for detrusor overactivity? Urology 63: 3-10, 2004.
11. Haefliger JA, Tissieres P, Tawadros T, Formenton A, Beny JL, Nicod P, Frey P, Meda P. Connexins 43 and 26 are differentially increased after rat bladder outlet obstruction. Exp Cell Res 274: 216-225, 2002.
12. Hanna-Mitchell AT, Beckel JM, Barbadora S, Kanai AJ, de Groat WC, Birder LA. Non-neuronal acetylcholine and urinary bladder urothelium. Life Sci 80: 2298-2302, 2007.
13. Ikeda Y, Fry C, Hayashi F, Stolz D, Griffiths D, Kanai A. Role of gap junctions in spontaneous activity of the rat bladder. Am J Physiol Renal Physiol 293: F1018-F1025, 2007.
14. Imamura M, Kanematsu A, Yamamoto S, Kimura Y, Kanatani I, Ito N, Tabata Y, Ogawa O. Basic fibroblast growth factor modulates proliferation and collagen expression in urinary bladder smooth muscle cells. Am J Physiol Renal Physiol 293: F1007-F1017, 2007.
15. Iwakura A, Tabata Y, Tamura N, Doi K, Nishimura K, Nakamura T, Shimizu Y, Fujita M, Komeda M. Gelatin sheet incorporating basic fibroblast growth factor enhances healing of devascularized sternum in diabetic rats. Circulation 104: 325-329, 2001.
16. Jia G, Mitra AK, Cheng G, Gangahar DM, Agrawal DK. Angiotensin II and IGF-1 regulate connexin43 expression via ERK and p38 signaling pathways in vascular smooth muscle cells of coronary artery bypass conduits. J Surg Res 142: 137-142, 2007.
17. Jiang JX, Gu S. Gap junction- and hemichannel-independent actions of connexins. Biochim Biophys Acta 1711: 208-214, 2005.
18. John H, Wang X, Wehrli E, Hauri D, Maake C. Evidence of gap junctions in the stable nonobstructed human bladder. J Urol 169: 745-749, 2003.
19. Kanematsu A, Yamamoto S, Iwai-Kanai E, Kanatani I, Imamura M, Adam RM, Tabata Y, Ogawa O. Induction of smooth muscle cell-like phenotype in marrow-derived cells among regenerating urinary bladder smooth muscle cells. Am J Pathol 166: 565-573, 2005.
20. Kanematsu A, Yamamoto S, Noguchi T, Ozeki M, Tabata Y, Ogawa O. Bladder regeneration by bladder acellular matrix combined with sustained release of exogenous growth factor. J Urol 170: 1633-1638, 2003.
21. Kardami E, Dang X, Iacobas DA, Nickel BE, Jeyaraman M, Srisakuldee W, Makazan J, Tanguy S, Spray DC. The role of connexins in controlling cell growth and gene expression. Prog Biophys Mol Biol 94: 245-264, 2007.
22. Kumar NM, Gilula NB. The gap junction communication channel. Cell 84: 381-388, 1996.
23. Li L, Jiang C, Hao P, Li W, Song C, Song B. Changes of gap junctional cell-cell communication in overactive detrusor in rats. Am J Physiol Cell Physiol 293: C1627-C1635, 2007.
24. Mattiasson A. Management of overactive bladder-looking to the future. Urology 50: 111-113, 1997.
25. Mori K, Noguchi M, Matsuo M, Nomata K, Suematsu T, Kanetake H. Decreased cellular membrane expression of gap junctional protein, connexin 43, in rat detrusor muscle with chronic partial bladder outlet obstruction. Urology 65: 1254-1258, 2005.
26. Neuhaus J, Pfeiffer F, Wolburg H, Horn LC, Dorschner W. Alterations in connexin expression in the bladder of patients with urge symptoms. BJU Int 96: 670-676, 2005.
27. Ouslander JG. Management of overactive bladder. N Engl J Med 350: 786-799, 2004.
28. Papa Petros PE. Detrusor instability and low compliance may represent different levels of disturbance in peripheral feedback control of the micturition reflex. Neurourol Urodyn 18: 81-91, 1999.
29. Segretain D, Falk MM. Regulation of connexin biosynthesis, assembly, gap junction formation, and removal. Biochim Biophys Acta 1662: 3-21, 2004.
30. Sohl G, Willecke K. An update on connexin genes and their nomenclature in mouse and man. Cell Commun Adhes 10: 173-180, 2003.
31. Solan JL, Lampe PD. Connexin phosphorylation as a regulatory event linked to gap junction channel assembly. Biochim Biophys Acta 1711: 154-163, 2005.
32. Soto-Gutierrez A, Kobayashi N, Rivas-Carrillo JD, Navarro-Alvarez N, Zhao D, Okitsu T, Noguchi H, Basma H, Tabata Y, Chen Y, Tanaka K, Narushima M, Miki A, Ueda T, Jun HS, Yoon JW, Lebkowski J, Tanaka N, Fox IJ. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol 24: 1412-1419, 2006.
33. Speakman MJ, Brading AF, Gilpin CJ, Dixon JS, Gilpin SA, Gosling JA. Bladder outflow obstruction-a cause of denervation supersensitivity. J Urol 138: 1461-1466, 1987.
34. Sui GP, Coppen SR, Dupont E, Rothery S, Gillespie J, Newgreen D, Severs NJ, Fry CH. Impedance measurements and connexin expression in human detrusor muscle from stable and unstable bladders. BJU Int 92: 297-305, 2003.
35. Tabata Y, Yamada K, Miyamoto S, Nagata I, Kikuchi H, Aoyama I, Tamura M, Ikada Y. Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogels. Biomaterials 19: 807-815, 1998.
36. Tambara K, Premaratne GU, Sakaguchi G, Kanemitsu N, Lin X, Nakajima H, Sakakibara Y, Kimura Y, Yamamoto M, Tabata Y, Ikeda T, Komeda M. Administration of control-released hepatocyte growth factor enhances the efficacy of skeletal myoblast transplantation in rat infarcted hearts by greatly increasing both quantity and quality of the graft. Circulation 112: 129-134, 2005.
37. Tanaka H, Kakizaki H, Shibata T, Ameda K, Koyanagi T. Effects of chronic blockade of N-methyl-D-aspartate receptors by MK-801 on neuroplasticity of the micturition reflex pathway after partial urethral obstruction in the rat. J Urol 170: 1427-1431, 2003.
38. Tanaka H, Kakizaki H, Shibata T, Mitsui T, Koyanagi T. Effect of preemptive treatment of capsaicin or resiniferatoxin on the development of pre-micturition contractions after partial urethral obstruction in the rat. J Urol 170: 1022-1026, 2003.
39. Wagner C. Function of connexins in the renal circulation. Kidney Int 73: 547-555, 2008.
40. Yamaguchi O, Honda K, Nomiya M, Shishido K, Kakizaki H, Tanaka H, Yamanishi T, Homma Y, Takeda M, Araki I, Obara K, Nishizawa O, Igawa Y, Goto M, Yokoyama O, Seki N, Takei M, Yoshida M. Defining overactive bladder as hypersensitivity. Neurourol Urodyn 26: 904-907, 2007.
41. Yoshimura N. Lower urinary tract symptoms (LUTS) and bladder afferent activity. Neurourol Urodyn 26: 908-913, 2007.
42. Yoshimura N, Bennett NE, Hayashi Y, Ogawa T, Nishizawa O, Chancellor MB, de Groat WC, Seki S. Bladder overactivity and hyperexcitability of bladder afferent neurons after intrathecal delivery of nerve growth factor in rats. J Neurosci 26: 10847-10855, 2006.
43. Yoshimura N, Chancellor MB. Current and future pharmacological treatment for overactive bladder. J Urol 168: 1897-1913, 2002.